The transwell-Matrigel invasion assay (Figures 3B, C) and wound healing assay (Figures 3D, E) further confirmed that PRL1 knockdown significantly reduced the invasiveness and migration capacity of the glioma cells respectively. This evidence concerns the gene PTP4A1 and central nervous system cancer.